Literature DB >> 11112788

Glucose and insulin function through two distinct transcription factors to stimulate expression of lipogenic enzyme genes in liver.

S H Koo1, A K Dutcher, H C Towle.   

Abstract

Transcription of a number of genes involved in lipogenesis is stimulated by dietary carbohydrate in the mammalian liver. Both insulin and increased glucose metabolism have been proposed to be initiating signals for this process, but the pathways by which these effectors act to alter transcription have not been resolved. We have previously defined by electrophoretic mobility shift assay a factor in nuclear extracts from rat liver, designated the carbohydrate-responsive factor (Cho- RF), that binds to liver-type pyruvate kinase and S(14) promoters at sites critical for regulation by carbohydrate. The sterol regulatory element binding protein-1c (SREBP-1c) has also emerged as a major transcription factor involved in this nutritional response. In this study, we examined the relationship between SREBP-1c and ChoRF in lipogenic gene induction. The two factors were found to possess distinct DNA binding specificities both in vitro and in hepatocytes. Reporter constructs containing binding sites for ChoRF were responsive to glucose but not directly to insulin. On the other hand, reporter constructs with an SREBP-1c site responded directly to insulin. The S(14) gene possesses binding sites for both ChoRF and SREBP, and both sites were found to be functionally important for the response of this promoter to glucose and insulin in hepatocytes. Consequently, we propose that SREBP-1c and ChoRF are independent transcription factors that mediate signals generated by insulin and glucose, respectively. For many lipogenic enzyme genes, these two factors may provide an integrated signaling system to support the overall nutritional response to dietary carbohydrate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112788     DOI: 10.1074/jbc.M010029200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  Glucose and cAMP: adversaries in the regulation of hepatic gene expression.

Authors:  H C Towle
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 2.  New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c.

Authors:  Fabienne Foufelle; Pascal Ferré
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

Review 3.  Signalling mechanisms linking hepatic glucose and lipid metabolism.

Authors:  M O Weickert; A F H Pfeiffer
Journal:  Diabetologia       Date:  2006-05-23       Impact factor: 10.122

4.  alpha(1)-fetoprotein transcription factor (FTF)/liver receptor homolog-1 (LRH-1) is an essential lipogenic regulator.

Authors:  Zhumei Xu; Lingli Ouyang; Antonio Del Castillo-Olivares; William M Pandak; Gregorio Gil
Journal:  Biochim Biophys Acta       Date:  2009-12-28

5.  Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis.

Authors:  Sushant Bhatnagar; Holly A Damron; F Bradley Hillgartner
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

6.  PGC-1β and ChREBP partner to cooperatively regulate hepatic lipogenesis in a glucose concentration-dependent manner.

Authors:  Kari T Chambers; Zhouji Chen; Ling Lai; Teresa C Leone; Howard C Towle; Anastasia Kralli; Peter A Crawford; Brian N Finck
Journal:  Mol Metab       Date:  2013-05-09       Impact factor: 7.422

Review 7.  Molecular mediators of hepatic steatosis and liver injury.

Authors:  Jeffrey D Browning; Jay D Horton
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

8.  Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice.

Authors:  Nathan A Ungerleider; Lara M Bonomi; Melissa L Brown; Alan L Schneyer
Journal:  Endocrinology       Date:  2013-03-26       Impact factor: 4.736

9.  Akt2 is required for hepatic lipid accumulation in models of insulin resistance.

Authors:  Karla F Leavens; Rachael M Easton; Gerald I Shulman; Stephen F Previs; Morris J Birnbaum
Journal:  Cell Metab       Date:  2009-11       Impact factor: 27.287

10.  Is there a relation between triglyceride concentrations in very low density lipoprotein and the index of insulin resistance in nondiabetic subjects?

Authors:  Yoshifumi Kurosaki; Tomoaki Tsukushi; Shinichi Munekata; Yuhsaku Kanoh; Tatsumi Moriya; Makoto Nishinari; Naoyoshi Aoyama; Zensuke Ogawa
Journal:  J Clin Lab Anal       Date:  2014-02-27       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.